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Hereditary xerocytosis (HX) is a rare disorder caused by defects of RBC permeability, associated with haemolytic anaemia of
variable degree and iron overload. It is sometimes misdiagnosed as hereditary spherocytosis or other congenital haemolytic
anaemia. Splenectomy is contraindicated due to increased risk of thromboembolic complications. We report the clinical,
haematological, and molecular characteristics of four patients from two unrelated Italian families affected by HX, associated
with beta-thalassemia trait and heterozygous pyruvate kinase deficiency, respectively. Two patients had been splenectomised and
displayed thrombotic episodes. All patients had iron overload in the absence of transfusion, two of them requiring iron chelation.
The diagnosis of HX was confirmed by LoRRca Osmoscan analysis showing a left-shifted curve. PIEZO1 gene sequencing revealed
the presence of mutation p.E2496ELE, showing that this is one of the most frequent mutations in this disease. The concomitant
defects did not aggravate the clinical phenotype; however, in one patient, the initial diagnosis of pyruvate kinase deficiency delayed
the correct diagnosis ofHX formany years and resulted in splenectomy followed by thrombotic complications.The study underlines
the importance of a precise diagnosis in HX, particularly in view of splenectomy, and the need of a molecular confirmation of
suspected RBC enzymopathy.
1. Introduction
Dehydrated stomatocytosis, also known as hereditary xero-
cytosis (HX, OMIM 194380), is the most frequent variant of
hereditary stomatocytoses, a group of rare disorders charac-
terized by a leak of monovalent cations (Na+ and K+) from
the red blood cells (RBCs) [1, 2]. In particular, in HX red cells
a decreased intraerythrocytic K+ and total cations content is
not accompanied by a proportional net gain of sodium and
water, ultimately resulting in erythrocyte dehydration [3].
HX patients usually present with mild to moderate chronic
haemolytic anaemia and splenomegaly, increased reticulo-
cyte count, and slight macrocytosis; moreover, erythrocyte
mean corpuscular haemoglobin concentration (MCHC) is
increased and erythrocyte osmotic fragility is decreased.
Blood smears show variable numbers of stomatocytes, but
usually less than 10% [1]; HX is characterized by a propen-
sity to iron overload [4]. The majority of HX cases has a
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mild presentation and may be overlooked for many years
or sometimes misdiagnosed as hereditary spherocytosis or
other congenital haemolytic anaemia [1]. However, unlike
hereditary spherocytosis in which it is highly beneficial,
splenectomy is contraindicated in HX due to increased risk
of thromboembolic complications [5–7].
Osmotic gradient ektacytometry, whichmeasures red cell
deformability, osmotic fragility, and cell hydration, is the
gold standard test for the definitive diagnosis and typically
shows a leftward shift of the bell-shaped curve [1, 8]. Sixteen
different mutations in PIEZO1 gene have been identified in 27
unrelated families with HX, primarily located in the highly
conserved COOH terminus of the protein [9–18]. Functional
studies of HX-associated PIEZO1 mutations demonstrate
a partial gain-of-function phenotype with many mutants
demonstrating delayed inactivation [10, 11, 19], suggesting
increased cation permeability that leads to HX erythrocyte
dehydration.
In this paper we report the clinical, haematological, and
molecular characterization of two unrelated Italian families
with HX due to mutation p.E2496ELE in PIEZO1 gene asso-
ciated with beta-thalassemia trait in one and heterozygous
pyruvate kinase (PK) deficiency in the other. By reviewing
the other cases reported in literature carrying the same
mutation, we exclude a synergetic effect between HX and the
concomitant disorders. In one patient the initial diagnosis
of pyruvate kinase deficient haemolytic anaemia delayed the
correct diagnosis of HX and resulted in splenectomy followed
by thrombotic complications.
2. Case Report
2.1. Family A. Two siblings, born after uncomplicated preg-
nancy form unrelated parents, were studied (Figure 1);
the father (AI.1) was reported to have chronic haemolytic
anaemia of unknown origin. AII.1 displayed chronic haemol-
ysis and jaundice since infancy; she was diagnosed with
PK deficiency on the basis of decreased enzyme activ-
ity and splenectomised in 1979 at the age of 21. After
splenectomy jaundice disappeared and Hb levels increased
from 9.4 to 11 g/dL, two episodes of deep vein thrombosis
(DVT) occurred, at the age of 26 and 54. Hyperferritinemia
(1162 ng/ml) was documented at the age of 46 and one cycle of
deferoxamine chelation was done for 3 months only because
of intolerance; at the age of 55 T2∗ MRI revealed marked
liver iron overload (𝑅 = 0.51) and patient started deferasirox
treatment.
AII.2 was first studied in 1992 at the age of 29 after his
wife’s first pregnancy interruption at 26 weeks of gestation for
severe hydrops foetalis attributed to parvovirus B19 infection.
On that occasion, Hb levels were 12.5 g/dL, reticulocytes were
316× 109/L, unconjugated bilirubinwas 5.9mg/dL, and serum
ferritin was 723 ng/ml; PK activity was slightly decreased
(10.2 IU/gHb, normal values 13.3 ± 2.29); however, because of
family history he was diagnosed with PK deficiency. Physical
examination revealed scleral jaundice and splenomegaly. He
underwent cholecystectomy at the age of 30. Both siblings
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Figure 1: Genealogical trees of the reported families.
were referred to our Centre for reevaluation of haemolytic
anaemia and iron overload.The patients’ clinical and haema-
tological data at the time of this study are shown in Table 1.
Both patients AII.1 and AII.2 displayed mild macro-
cytic anaemia and reticulocytosis, 13–15% stomatocytes in
peripheral blood smear examination with 7% target cells, and
2–4% schistocytes, ovalocytes, and spherocytes (Figure 2).
Increased serum ferritin levels were also detected in the
absence of blood transfusions; HFE genotype was H63D/wt.
Interestingly AII.1 showed mild spectrin deficiency with
normal EMA binding test. RBC PK activity was decreased
in both siblings (7 IU/gHb and 10.8 IU/gHb, resp.). Direct
sequencing of the entire coding region, intronic flanking
regions, and promoter of PK-LR gene showed heterozygosity
for the c.257G>Amutation (p.R86H). Because PK deficiency
is an autosomal recessive disease this finding allowed exclud-
ing the previous diagnosis of PK deficiency and prompted
us to investigate other causes of haemolysis in this family;
the RBC morphology, the apparent dominant transmission,
and the history of DVT in the splenectomised patient were
suggestive of hereditary stomatocytosis.
LoRRca Osmoscan (Figure 3(a)) showed in AII.2 a left
shift of the curve (Omin 156, n.v. 151–175; Ohyper 456,
n.v. 473–534), indicating the presence of dehydrated red
cells. In AII.1, a more pronounced left shift (Omin 119,
Ohyper 428), was also associated with decreased EImax
(0.541, n.v. 0.586–0.610), in line with the spectrin deficiency
detected by SDS-PAGE analysis. PIEZO1 gene sequencing
revealed in both siblings heterozygosity for the mutation
c.7479_7484dupGGAGCT in exon 51 (p.E2496ELE), thus
confirming the diagnosis of HX.
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Table 1: Clinical and haematological data of the patients at the time of the study.
AII.1# AII.2 BII.1# BIII.1 Normal values
Sex F M F F
Age 55 50 39 9
Detection of anaemia Infancy 29 yrs 15 yrs Birth
Splenectomy (age) Yes (21) No Yes (24) No
Cholecystectomy (age) No Yes (30) Yes (24) No
Transfusions No No No No
Hb (g/dL) 11 13 12 10.8 F 12–16; M 13.5–17.5
MCV (fl) 108 103 100 66.4∗ 78–99
MCH (pg) 39.7 39.2 38.1 24.1 25–35
MCHC (g/dL) 36.5 37.8 38 36.2 31–37
Reticulocytes (×109/L) 166 273 198 423 24–84
Stomatocytes (%) 13 15 33 22
PLTs (×109/L) 696 172 875 329 130–400
WBCs (×109/L) 8.4 7.68 9.31 8.15 4.8–10.8
Unconj bilirubin (mg/dL) 1.33 4.82 1.33 2.8 <0.8
Serum iron (𝜇g/dL) 101 150 167 n.a. 59–158
Serum ferritin (ng/mL) 745 1571 356 321 F 15–150; M 30–400
Transferrin (𝜇g/dL) 149 170 237 221 200–360
Transferrin saturation (%) 56 71 75 n.a. 16–54
GLT (sec) 180 68 480 195 23–45
AGLT (sec) >900 >900 >900 >900 >900
NaCl osmotic fragility Reduced Reduced Reduced Reduced
Pink test (%) 27 28 16 16 11–33
EMA binding test Normal Normal n.a. n.a.
Sp/Bd3 ratio 0.90 1.14 1.11 1.05 0.97–1.19
HFE genotype H63D/wt H63D/wt wt/wt n.a. wt/wt
Gilbert genotype 6/6 6/6 6/7 n.a. 6/6
PK activity (IU/gHb) 7 10.8 nd nd 11.9–16.1
2,3 DPG (nmol/gHb) n.a. 14183 nd nd 10540 ± 1720
ATP n.a. 5674 nd nd 4231 ± 630
PK-LR genotype c.257G>A/wt c.257G>A/wt nd nd
∗𝛽-Thalassemia trait; n.a. = not available; nd = not determined.
#Postsplenectomy.
2.2. Family B. Patient BII.1 was first recognized to be anaemic
at the age of 15 years because of scleral jaundice; at the age
of 23 in 1995 she was diagnosed with hereditary stomato-
cytosis based on the presence of stomatocytes at peripheral
blood smear examination (12%); in that occasion, she had
Hb 11.9 g/dL, MCV 95 fL, reticulocytes 550 × 109/L, serum
ferritin 421 ng/ml, transferrin saturation 70%, and uncon-
jugated bilirubin 6.7mg/dL. Abdominal ultrasound showed
splenomegaly (18 × 12 cm), hepatomegaly, and gallstones.
Family study revealed in the mother (BI.1) a compensated
haemolysis (Hb 12.6 g/dL, reticulocytes 311 × 109/L, and
unconjugated bilirubin 2mg/dL) with 11% stomatocytes,
suggesting dominant transmission of the disease.
One year later the patient underwent cholecystectomy
for gallstones, associated with splenectomy. Surgery had no
effect on Hb levels; postsplenectomy reticulocytes were 200–
300 × 109/L and serum ferritin was 300–400 ng/ml. At the
age of 30 years, the patient became pregnant and she gave
birth to a girl (BIII.1); pregnancy was complicated by gestosis,
with delivery at 35 weeks. At birth the child was admitted
4 Case Reports in Hematology
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Figure 2: Light microscopy of peripheral blood, 63x.
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Figure 3: Results of LoRRca Osmoscan analysis in the affected patients compared to a normal control performed by Laser-Assisted Optical
Rotation Cell Analyzer (LoRRca MaxSis, Mechatronics, Hoorn, The Netherlands). The osmotic gradient curves reflect RBC deformability as
a continuous function of suspendingmedium osmolality.The following parameters were evaluated: EImax (maximal deformability, reflecting
mean cellular surface area), Omin (osmolality at which deformability reaches its minimum, reflectingmean cellular surface-to-volume ratio),
and Ohyper (the osmolality in the hypertonic region corresponding to 50% of the EImax, reflecting mean cellular hydration status).
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to the Intensive Care Unit for neonatal immaturity and res-
piratory distress, and she was diagnosed with hereditary
stomatocytosis associated with beta-thalassemia trait (Hb
10.6 g/dL, MCV 71.9 fL, stomatocytes 22%, reticulocytes 260
× 109/L, and unconjugated bilirubin 1.09mg/dL).
The mother and daughter were referred to our hospital
for reevaluation of their anaemia and to confirm the diag-
nosis at molecular level. At the last follow-up patient BII.1
reported that a thromboembolic event occurred 20 years after
splenectomy. Patient BII.1 displayed compensated haemolytic
anaemia with 22% stomatocytes at peripheral blood smear
examination, 13% target cells, and 2% schistocytes (Table 1
and Figure 2). Ferritin levels and transferrin saturation were
increased in the presence of a normal HFE genotype. Bone
marrow evaluation showed marked dyserythropoiesis. Case
BIII.1 had mild microcytic anaemia, reticulocytosis, and
increased ferritin levels; 17% of stomatocytes were detected at
blood smear examination (Table 1 and Figure 2); the molecu-
lar testing for HBB gene revealed the presence of the splicing
mutation c.93-21G>A at heterozygote level, confirming the
beta-thalassemia trait.
LoRRca Osmoscan (Figure 3(b)) showed the pronounced
left shift of the curve typical of dehydrated stomatocytosis
(Omin 71 and 76, resp., n.v. 136–151; Ohyper 342 and 352, n.v.
447–474). PIEZO1 gene sequencing revealed in both cases the
presence of the mutation p.E2496ELE.
3. Discussion
There is an increasing interest in defects of RBC permeability
due to the recent advances in knowledge of their molecular
bases. Considered to be a group of very rare diseases, the
number of reported cases of HX in the past three years is
increased after the identification of the causative genes, such
as PIEZO1 [9–11] and, more recently, KCNN4 codifying for
Gardos channel [20–23].
The wide heterogeneity of clinical presentation and in
particular the occurrence of mild/compensated cases may
contribute to delay of the diagnosis [14, 16]. Moreover, some
patients displaying very few stomatocytes at the blood film
examination may be misdiagnosed as hereditary spherocy-
tosis or as suffering from an enzyme deficiency [1]. This was
the case in patient AII.1, initially diagnosed as PK deficiency
based on decreased enzyme activity, who underwent splenec-
tomy and was eventually identified as HX with 30-year delay:
the apparently dominant transmission of the anaemia, the
absence of the expected increase of reticulocytes number after
splenectomy, and PK-LR genotyping showing monoallelic
mutation ruled out the diagnosis of PK deficiency as a
primary cause of haemolysis. This case therefore pinpoints
the need of confirming a suspected RBC enzymopathy at the
molecular level.
More than in other haemolytic anaemia, a precise diagno-
sis is of the utmost importance in HX in light of the increased
risk of thrombotic complications following splenectomy [5–
7] reported in all the splenectomised patients with PIEZO1
mutations but one. Patient AII.1 displayed two DVT episodes
5 and 33 years after splenectomy, and patient BII.1 had
pulmonary embolism 20 years after surgery. It is worth
mentioning that the only patient reported in the literature
without thromboembolic complication after splenectomy
had a relatively short follow-up [17].
Although usually well compensated and requiring no
blood transfusions, dehydrated stomatocytosis is a heavily
iron loading condition [4, 14], as also shown in our cases.
The causes of this are not well established: haemolysis is
commonly mild and it is unlikely to be per se the main cause
of iron overload. An important factor in this regard may be
dyserythropoiesis, whichwas also present in patient BII.1.The
occurrence of dyserythropoiesis has been documented in a
variant of hereditary stomatocytosis due to Gly796Arg muta-
tion of the erythroid anion exchanger [24] and in one case
withHXassociatedwith hereditary high phosphatidylcholine
haemolytic anaemia [17] but excluded in another PIEZO1
mutated patient described by Archer et al. [14].
HX has been long known to be a pleiotropic syndrome
which combines in some families with haemolytic anaemia
and perinatal edema; the latter, usually transient and of rela-
tively benign prognosis [25–28], has been recently correlated
withPIEZO1mutation byAndolfo et al. [10].Thenonimmune
foetal hydrops recorded in family A is the most severe form
so far described in patients with PIEZO1mutations.
LoRRca Osmoscan proved to be very useful in orienting
the diagnosis towardHX, later confirmed by the PIEZO1 gene
analysis. Interestingly, patient AII.1 also displayed a decrease
in EImax, as found in the case reported by Grootenboer-
Mignot et al. [27]. In our patient the decrease in EImax is
in line with the SDS-PAGE finding of a moderate spectrin
deficiency. Spectrin deficiency in the absence of anymutation
in RBC cytoskeletal proteins documented by whole exome
sequencing has been reported in hereditary stomatocytosis
due to KCNN4 mutation [23] and considered to be a sec-
ondary effect of a membrane perturbation [29, 30] disclosed
by splenectomy [31].
All the four patients here described were heterozygous
formutation p.E2496ELE.Themutationwas already reported
in 8 unrelated cases described by Albuisson et al. [11] and
very recently in a Japanese family [17] (Table 2). Although
being also detected in 2 of 600 healthy French controls, this
mutation was considered pathogenic; in fact, patch-clamp
experiments in transfected HEK293 cells demonstrated a
considerable increase in the inactivation time in the mutant
compared to wild-type channel kinetics, indicating that it
represents a gain-of-function mutation [11]. The finding of
p.E2496ELEmutation also in our unrelated families (the first
two families of Italian origin characterized atmolecular level)
supports its pathogenicity and confirms that this is one of
the most frequent mutations in HX, with 15 patients so far
reported in literature.
Combined defects of red cell membrane and/or meta-
bolism are very rare, and the fact that carriership for a meta-
bolic defect may be a modifier for the clinical expression
of a membrane defect is still debated [32, 33]; in particular,
the copresence of beta-thalassemia trait seems to reduce the
degree of haemolysis in patients with hereditary spherocy-
tosis [34–37]. In the presented cases the clinical phenotype
does not differ from the HX cases reported in literature
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(Table 2), thus excluding a synergetic effect between HX and
the concomitant disorders.
In conclusion, our data underline the importance of a
precise diagnosis in HX, particularly in view of splenectomy
because of the increased thrombotic risk, and the need of a
molecular confirmation of a suspected RBC enzymopathy.
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